← FDA Drug Approvals (Drugs@FDA)

EPINEPHRINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HLDING · Approved 2026-07-31

Drug application

FDA Application #

ANDA217426

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPINEPHRINE

Generic name

Epinephrine

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

DEVA HLDING

First approval

2026-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown